SkyQuest Technology Group has recently published a comprehensive Fertility Supplements Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. The purpose of the fertility supplements market is to provide individuals with an alternative solution to improve their reproductive health and increase their chances of conceiving. The increasing prevalence of infertility is a major driving factor for the fertility supplements market. Additionally, rising awareness of the benefits of using dietary supplements to improve reproductive health and the availability of these supplements over the counter are also contributing to the growth of the market.
Fertility Supplements Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.26 billion in 2024 to USD 4.09 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).
The lack of regulatory oversight and inconsistent product quality is a significant restraining factor for the fertility supplements market. Additionally, the high cost of some supplements may also limit their accessibility to some individuals. The absence of scientific proof demonstrating these supplements’ ability to increase fertility is one of the major obstacles facing the market for fertility supplements. Furthermore, the stigma attached to infertility and some people’s unwillingness to seek treatment could have an effect on the market’s growth.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/fertility-supplements-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Fertility Supplements Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Fertility Supplements Market is segmented by Ingredient Type, Product, Distribution Channel, End User and region.
Based on Ingredient Type, the market is segmented into Natural and Synthetic.
Based on Product, the market is segmented into Capsules, Tablets, Soft gels, Powders and Liquids.
Based on Distribution Channel, the market is segmented into OTC and Prescribed.
Based on End User, the market is segmented into Men and Women.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Fertility Supplements Market – Regional Analysis:
North America held the largest share in the global fertility supplements market. Data from the Centers for Disease Control and Prevention (CDC) update indicated that 14.1% of women aged 15 to 49 in the U.S. had impaired fertility, while 15.1% of married women aged 15 to 49 had impaired fertility.
Furthermore, the market in Canada is expected to grow rapidly due to initiatives by the government and nonprofit organizations such as Fertility Matters Canada to raise awareness about fertility medication and treatment, as well as the rising rates of obesity and sexually transmitted infections.
Asia Pacific is expected to experience significant growth in the fertility supplement market, with a projected CAGR of 12.0% from 2022 to 2030. The region offers promising opportunities for leading companies due to increased accessibility and availability of healthcare facilities, as well as increased expenditure in the research and healthcare sectors.
Top Market Players in Fertility Supplements Market are:
Fairhaven Health (USA)
Coast Science (USA)
Lenus Pharma GesmbH (Austria)
Active Bio Life Science GmbH (Germany)
Orthomol (Germany)
Exeltis USA, Inc. (USA)
Bionova (India)
Fertility Nutraceuticals LLC (USA)
Vitabiotics Ltd. (UK)
Extreme V, Inc. (USA)
Xena Bio Herbals Pvt. Ltd. (India)
Gonadosan Distribution GmbH (Fertilovit) (Austria)
InnovaMed Ltd. (Amino Expert) (UK)
Babystart Ltd. (UK)
Crown Nutraceuticals (USA)
Sal Nature LLC (USA)
Yadtech (Israel)
Prega News (India)
PlusPlus Lifesciences LLP (India)
Fertility Supplements Market Recent Developments:
In November 2023, Los Angeles based perinatal supplement startup Needed raised $14 million to study pregnant people’s nutritional needs.
In August 2023, Sexual wellness brand HANX unveiled two new natural supplements – Menopause Support and Pregnancy Support. These offerings, developed in-house by HANX Co-Founder Dr. Sarah Welsh, a former NHS gynaecology and obstetrics doctor, promise to provide much-needed assistance to women during crucial life stages.
In October 2021, Everly Health bought startup Natalist to expand its reach into women’s health, retail products. Natalist offers women’s health, conception and pregnancy products, such as prenatal supplements and pregnancy and ovulation tests.
You may Also Like
https://issuu.com/skyquest-technology/docs/is_stearyl_alcohol_market_set_to_expand_with_risin
https://issuu.com/suleymanscout/docs/solar_pv_market_to_reach_usd_2_514.02_billion_by_2/s/65903724
Forward-Looking Insights
The Fertility Supplements Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
